CUVL · NASDAQ · Medical - Pharmaceuticals

Clinuvel Pharmaceuticals (ADR) (CUVL)

Commercializes SCENESSE® for adult EPP and develops melanocortin therapies.

$5.80
After hours+0.02 (+0.35%)
At close$5.78(−0.34%)

Not reported.